Nutex Health, Inc.NUTXEarnings & Financial Report
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
Revenue
$267.8M
Gross Profit
$154.9M
Operating Profit
$130.4M
Net Profit
$55.4M
Gross Margin
57.8%
Operating Margin
48.7%
Net Margin
20.7%
YoY Growth
239.9%
EPS
$7.76
Nutex Health, Inc. Q3 FY2025 Financial Summary
Nutex Health, Inc. reported revenue of $267.8M (up 239.9% YoY) for Q3 FY2025, with a net profit of $55.4M (up 730.8% YoY) (20.7% margin). Cost of goods sold was $112.9M, operating expenses totaled $24.5M.
Key Financial Metrics
| Total Revenue | $267.8M |
|---|---|
| Net Profit | $55.4M |
| Gross Margin | 57.8% |
| Operating Margin | 48.7% |
| Report Period | Q3 FY2025 |
Revenue Breakdown
Nutex Health, Inc. Q3 FY2025 revenue of $267.8M breaks down across 2 segments, led by Hospital Division at $260.2M (97.2% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Hospital Division | $260.2M | 97.2% |
| Population Health Management Division | $7.6M | 2.8% |
Nutex Health, Inc. Revenue by Segment — Quarterly Trend
Nutex Health, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Hospital Division and Population Health Management Division) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Hospital Division | $143.7M | $260.2M | $236.3M | $203.9M |
| Population Health Management Division | $8.0M | $7.6M | $7.7M | $7.8M |
Nutex Health, Inc. Annual Revenue by Year
Nutex Health, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $875.3M).
| Year | Annual Revenue |
|---|---|
| 2025 | $875.3M |
| 2024 | $479.9M |
| 2023 | $247.6M |
| 2022 | $219.9M |
Nutex Health, Inc. Quarterly Revenue & Net Profit History
Nutex Health, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $151.7M | -41.1% | $11.8M | 7.8% |
| Q3 FY2025 | $267.8M | +239.9% | $55.4M | 20.7% |
| Q2 FY2025 | $244.0M | +220.7% | $-17.7M | -7.3% |
| Q1 FY2025 | $211.8M | +214.0% | $21.2M | 10.0% |
| Q4 FY2024 | $257.6M | +269.8% | $61.6M | 23.9% |
| Q3 FY2024 | $78.8M | +25.6% | $-8.8M | -11.2% |
| Q2 FY2024 | $76.1M | +29.1% | $-364.0K | -0.5% |
| Q1 FY2024 | $67.5M | +19.7% | $-364.0K | -0.5% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $67.5M | $76.1M | $78.8M | $257.6M | $211.8M | $244.0M | $267.8M | $151.7M |
| YoY Growth | 19.7% | 29.1% | 25.6% | 269.8% | 214.0% | 220.7% | 239.9% | -41.1% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $404.3M | $422.4M | $438.5M | $655.3M | $761.9M | $841.0M | $964.5M | $918.5M |
| Liabilities | $324.3M | $340.4M | $358.7M | $466.8M | $506.6M | $504.2M | $526.5M | $495.1M |
| Equity | $63.0M | $62.7M | $60.4M | $132.4M | $176.9M | $235.3M | $317.2M | $329.4M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $3.1M | $13.3M | $6.8M | $54000 | $51.0M | $27.3M | $99.5M | $70.4M |